Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 245
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Can Pet Visits Help Kids With Cancer?

Cancer is hard on kids and their families. Can visits from therapy animals make the time they spend in the...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

Backer Badge Funded